Glucagon II pp 645-666 | Cite as

Glucagon in the Diagnosis and Treatment of Hypoglycaemia

  • V. Marks
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 66 / 2)

Abstract

Two of glucagon’s many pharmacological properties are utilised clinically for the diagnosis and treatment of hypoglycaemia. They are its ability: (1) to raise the blood glucose concentration by increasing hepatic glycogenolysis; and (2) to stimulate insulin secretion by direct action on pancreatic B-cells. Though still widely used for the treatment of acute episodes of iatrogenic hypoglycaemia in insulin-dependent subjects, the advent of more specific and more effective treatments has reduced almost to zero the usefulness of glucagon as a therapy for chronic hypoglycaemia. Similarly, the availability of improved diagnostic procedures for hyperinsulinism, glycogen storage disease and the various endocrinopathies associated with, and causative of, spontaneous hypoglycaemia has reduced the usefulness of glucagon in the differential diagnosis of these disorders to that of an adjunct rather than a key.

Keywords

Obesity Adenoma Schizophrenia Folate Glucocorticoid 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alaric R (1973) Hypoglycémie prolongée au chlorpropamide. Union Med Can 102: 1290–1291Google Scholar
  2. Alivisatos JG, McCullagh EP (1955) Studies with glucagon in patients with insulin sensitivity. JAMA 159: 1098–1105Google Scholar
  3. Arieff A, Crawford J, Adams J, Smith D (1960) Glucagon in insulin coma therapy: its use in a small psychiatric unit of a general hospital. Q Bull Northwest Univ Med Sch 34: 7–10PubMedGoogle Scholar
  4. Arky RA, Finger M, Veverbrants E, Braun AP (1970) Glucose and insulin response to intravenous glucagon during starvation. Am J Clin Nutr 23: 69–95PubMedGoogle Scholar
  5. Aynsley-Green A, Williamson DH, Gitzelmann R (1977) Hepatic glycogen synthetase deficiency: definition of syndrome and enyzme studies on a 9-year-old girl. Arch Dis Child 52: 573–579PubMedGoogle Scholar
  6. Baerlocher K, Gitzelmann R, Steinman B, Gitzelmann-Cumarasamy N (1978) Hereditary fructose intolerance in early childhood: a major challenge. Survey of 20 symptomatic cases. Helv Paediatr Acta 33: 465–487PubMedGoogle Scholar
  7. Baker L, Winegrad AI (1970) Fasting hypoglycaemia and metabolic acidosis associated with deficiency of hepatic fructose-1,6-diphosphatase activity. Lancet 2: 13–16PubMedGoogle Scholar
  8. Beck-Christiansen O (1964) Metastasizing insulinoma treated with glucagon. Dan Med Bull 11: 70–72PubMedGoogle Scholar
  9. Benedetti A (1971) The glucagon plus galactose tolerance. In: Austoni M, Scandellari C, Federspil G, Trisotto A (eds) Current topics on glucagon. Cedam, Padova, pp 177–191Google Scholar
  10. Benedetti A, Kolb FO (1966) Metabolic effects and epinephrine in four adults with type I glycogen storage disease. Diabetes 15: 529Google Scholar
  11. Benedetti A, Simpson RG, Grodsky GM, Forsham PH (1967) Exaggerated insulin response to glucagon in simple obesity. Diabetes 16: 666–669PubMedGoogle Scholar
  12. Bergman H (1965) Hypoglycaemic coma during sulphonylurea therapy. Acta Med Scand 177: 287–298PubMedGoogle Scholar
  13. Braun M, Parker M (1959) The use of glucagon in the termination of therapeutic insulin coma. Am J Psychiatry 115: 814–815PubMedGoogle Scholar
  14. Brennan MO, Service F J, Carpenter AM, Rubenstein AH, Edis AJ (1980) A complex case of hypoglycemia diagnosed by C-peptide suppression test. In: Andreani D, Lefèbvre PJ, Marks V (eds) Current views on hypoglycaemia and glucagon. Academic, London, pp 321–330Google Scholar
  15. Broberger O, Jungner I, Zetterstrôm R (1959) Studies in spontaneous hypoglycemia in childhood: failure to increase the epinephrine secretion in insulin-induced hypoglycemia. J Pediatr 55: 713–719PubMedGoogle Scholar
  16. Carson MJ, Koch R (1955) Clinical studies with glucagon in children. J Pediatr 47:161–170Google Scholar
  17. Chalmers RA, Ryman BE, Watts RWE (1978) Studies on a patient with in vivo evidence of type I glycogenosis and normal enzyme activities in vitro. Acta Paediatr Scand 67: 201–207PubMedGoogle Scholar
  18. Charles MA, Hofeldt F, Shackleford A, Waldeck N, Dobson LE, Bunker D, Coggins JT, Eichner H (1981) Comparison of oral glucose tolerance tests and mixed meals in patients with apparent idiopathic postabsorptive hypoglycemia: absence of hypoglycemia after meals. Diabetes 30: 465–470PubMedGoogle Scholar
  19. Chowdhury F, Bleicher S J (1973) Studies of tumor hypoglycemia. Metabolism 22: 663–674PubMedGoogle Scholar
  20. Codaccioni JL, Rubin P, Mattei A, Vague P (1971) Quatre hypoglycémies graves donc une mortelle au cours du traitement par glibenclamide. Diab Metab 19: 37–41Google Scholar
  21. Colle E, Ulström RA (1964) Ketotic hypoglycemia. J Pediatr 64: 632–651PubMedGoogle Scholar
  22. Colwell JA, Wilber JF (1971) Studies of insulin and growth hormone secretion in a subject with hepatoma and hypoglycemia. Diabetes 20: 607–614PubMedGoogle Scholar
  23. Cornblath M, Schwartz R (1976) Disorders of carbohydrate metabolism in infancy, 2nd edn. Saunders, PhiladelphiaGoogle Scholar
  24. Creutzfeldt W, Frerichs H, Perings F (1969) Serum insulin levels in hypoglycaemic shock due to attempted suicide with tolbutamide and insulin. Ger Med Monthly 14: 14–19Google Scholar
  25. Creutzfeldt W, Arnold R, Creutzfeldt C, Deuticke U, Frerichs H, Track NS (1973) Biochemical and morphological investigations of 30 human insulinomas. Correlation between the tumour content of insulin and proinsulin-like components and the histological and ultrastructural appearance. Diabetologia 9: 217–231Google Scholar
  26. Creutzfeldt W, Creutzfeldt C, Frerichs H, Track NS, Arnold R (1976) Histochemistry, ultrastructure and hormone content of human insulinomas. In: Andreani D, Lefebvre P, Marks V (eds) Hypoglycemia. Proceedings of the European Symposium, Rome. Thieme, Stuttgart, pp 7–18Google Scholar
  27. Crockford PM, Porte D, Wood FC, Williams RH (1966) Effect of glucagon on serum insulin, plasma glucose and free fatty acids in man. Metabolism 15: 114–122PubMedGoogle Scholar
  28. Davies DM, Maclntyre A, Millar E, Bell SM, Mehra SK (1967) Need for glucagon in severe hypoglycaemia induced by sulphonylurea drugs. Lancet 1: 363–364PubMedGoogle Scholar
  29. Devrim S, Recant L (1966) Effect of glucagon on insulin release in vitro. Lancet 2: 1227–1228PubMedGoogle Scholar
  30. Dowell RC, Imrie AH (1972) Chlorpropamide poisoning in non-diabetics. Scott Med J 17: 305–309PubMedGoogle Scholar
  31. Elrick H, Arai Y, Yearwood-Drayton V (1957) Observation on actions of combined glucagon-insulin infusion in diabetic patients. J Clin Invest 36: 887–888Google Scholar
  32. Elrick H, Witten TA, Arai Y (1958) Glucagon treatment of insulin reactions. N Engl J Med 258: 476–480PubMedGoogle Scholar
  33. Esquibel AJ, Kurland AA, Mendelsohn D (1958) The use of glucagon in terminating insulin coma. Dis Nerv Syst 19: 485–486PubMedGoogle Scholar
  34. Falorni A, Massi-Benedetti F, Sposito M, Barboni G, Latom M (1979) Insulin and glucagon secretion in the ketotic (idiopathic glucagon unresponsive) hypoglycemia of childhood. J Endocrinol Invest 2: 51–57PubMedGoogle Scholar
  35. Fernandez J (1980) Hepatic glycogenosis: diagnosis and management. In: Burman D, Holton JB, Pennock CA (eds) Inherited disorders of carbohydrate metabolism. MTP Press, Lancaster, pp 297–312Google Scholar
  36. Fernandez J, Koster JF, Grose WFA, Sorgedrager N (1974) Hepatic phophorylase deficiency: its differentiation from other hepatic glycogenoses. Arch Dis Child 49: 186–191Google Scholar
  37. Finegold DN, Stanley CA, Baker L (1980) Glycemic response to glucagon during fasting hypoglycaemia: an aid to the diagnosis of hyperinsulinism. J Pediatr 96: 257–260PubMedGoogle Scholar
  38. Fiser RH, Meisher HL, Fischer DA (1974) Hepatic phosphoenolypyruvate carboxykinase (PEPCK) deficiency: a new cause of hypoglycemia in childhood ( Abstr ). Pediatr Res 8: 432Google Scholar
  39. Foä PP, Dunbar JC, Klein SP, Levy SH, Malik MA, Campbell BB, Foä NL (1980) Reactive hypoglycemia and A-cell (pancreatic) glucagon deficiency in the adult. JAMA 244: 2281–2285PubMedGoogle Scholar
  40. Forman BH, Feeney E, Boas L (1974) Drug induced hypoglycemia. JAMA 229: 522PubMedGoogle Scholar
  41. Forrest JAH (1974) Chlorpropamide overdosage. Delayed and prolonged hypoglycemia. Clin Toxicol 7: 19–24PubMedGoogle Scholar
  42. Frasier SD, Smith FG, Nash A (1965) The use of glucagongel in idiopathic spontaneous hypoglycemia of infancy. Pediatrics 35: 120–123PubMedGoogle Scholar
  43. Frerichs H, Willms B, Kasper H, Creutzfeldt C, Creutzfeldt W (1970) Contribution to the pathogenesis of tumour hypoglycaemia. Eur J Clin Invest 1: 2–11PubMedGoogle Scholar
  44. Frey HMM, Roselund B (1970) Studies in patients with chlorpropamide-induced hypoglycemia. Diabetes 19: 930–937PubMedGoogle Scholar
  45. Friend JAR, Hales CN (1965) Spontaneous hypoglycaemia and sarcoma. Acta Endocrinol (Copenh) 50: 233–238Google Scholar
  46. Froesch ER (1978) Essential fructosuria: hereditary fructose intolerance and fructose 1,6- diphosphatase deficiency. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease, 4th edn. McGraw-Hill, New York, pp 121–136Google Scholar
  47. Gibbs GE, Ebers DW, Meckel BR (1958) Use of glucagon to terminate insulin reactions in diabetic children. Nebr State Med J 43: 56–57PubMedGoogle Scholar
  48. Goldfine ID, Cerasi E, Luft R (1972) Glucagon stimulation of insulin release in man: inhibition during hypoglycemia. J Clin Endocrinol Metab 35: 312–315PubMedGoogle Scholar
  49. Gotlin RW, Silver HK (1970) Neonatal hypoglycaemia, hyperinsulinism, and absence of pancreatic alpha-cells. Lancet 1: 1346Google Scholar
  50. Greenman L (1950) Alterations in blood glucose following intravenous galactose. J Biol Chem 183: 577–585Google Scholar
  51. Grill V, Cerasi E, Wahren J (1979) Role of cyclic AMP in glucagon-induced stimulation of hepatic glucose output in man. Scand J Clin Invest 39: 689–696PubMedGoogle Scholar
  52. Grollman A, McCaleb WE, White FN (1964) Glucagon deficiency as a cause of hypoglycemia. Metabolism 13: 686–690PubMedGoogle Scholar
  53. Grunt JA, McGarry ME, McCollum AT, Gould JB (1970) Studies of children with ketotic hypoglycemia. Yale J Biol Med 42: 420–438PubMedGoogle Scholar
  54. Habbick BF, McNeish AS, Stephenson JBP (1971) Diagnosis of ketotic hypoglycaemia of childhood. Arch Dis Child 46: 295–300PubMedGoogle Scholar
  55. Haro EN, Blum SF, Faloon WW (1965) The glucagon response of fasting obese subjects. Metabolism 14: 976–984PubMedGoogle Scholar
  56. Haunz EA (1962) Feigned insulin reactions in diabetic children prevented by glucagon. Lancet 82: 263–268Google Scholar
  57. Hoffbrand BI, Sevitt LH (1966) Use of mannitol in prolonged coma due to insulin overdose. Lancet 1: 802Google Scholar
  58. Hommes FA, Bendien K, Elema JD, Bremer HJ, Lombeck I (1976) Two cases of phosphoenolpyruvate carboxykinase deficiency. Acta Paediatr Scand 65: 233–240PubMedGoogle Scholar
  59. Hommes FA, Schrijver J, Dias T (1980) Pyruvate carboxylase deficiency; studies on patients and on an animal model system. In: Burman D, Holton JB, Pennock CA (eds) Inherited disorders of carbohydrate metabolism. MTP Press, Lancaster, pp 269–286Google Scholar
  60. Horwitz DL, Rubenstein AH (1974) Insulin suppression (letter). Lancet 2: 1021PubMedGoogle Scholar
  61. Howell RR (1978) The glycogen storage diseases. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease. Blakiston, New York, pp 137–159Google Scholar
  62. Hubble D (1954) Glucagon and glycogen storage disease of the liver. Lancet 1: 235–237Google Scholar
  63. Hug G (1962) Glucagon tolerance test in glycogen storage disease. J Pediatr 60: 545–549PubMedGoogle Scholar
  64. Hug G, Krill CE, Perrin EV, Guest GM (1963) Cori’s disease (amylo 1,6 glucosidase deficiency): report of a case in a negro child. N Engl J Med 268: 113–120PubMedGoogle Scholar
  65. Jacobs RF, Nix RA, Paulus JE, Kiel EA, Fiser RH (1978) Intravenous infusion of diazoxide in the treatment of chlorpropamide-induced hypoglycemia. J Pediatr 93: 801–803PubMedGoogle Scholar
  66. Jaffe R, Hashida Y, Yunis EJ (1980) Pancreatic pathology in hyperinsulinemic hypoglycemia of infancy. Lab Invest 42: 356–365PubMedGoogle Scholar
  67. Joffe BI, Roach L, Baker S, Shires R, Sandler M, Seftel HC (1981) Failure to induce reactive hypoglycaemia by drinking a starch-based alcohol beverage (sorghum beer). Ann Clin Biochem 18: 22–24PubMedGoogle Scholar
  68. Johnson SF, Schade DS, Peake GT (1977) Chlorpropamide-induced hypoglycemia. Successful treatment with diazoxide. Am J Med 63: 799–804Google Scholar
  69. Kerr DS (1980) Epinephrine deficiency in children: fasting metabolism and response to 2-deoxyglucose. In: Andreani D, Lefebvre PJ, Marks V (eds) Current views on hypoglycaemia and glucagon. Academic Press, London New York, pp 409–412Google Scholar
  70. Khurana RC, Klayton R, Jung Y, Gonzalez AR, Dhawer VPS, Corredor DG, Sieracki JC, Danowski TS (1971) Insulin and glucose patterns in control subjects and in proved insulinoma. Am J Med Sei 262: 115–118Google Scholar
  71. Kollee LA, Monnens LA, Cejka V, Wilms RH (1978) Persistent neonatal hypoglycaemia due to glucagon deficiency. Arch Dis Child 53: 422–424PubMedGoogle Scholar
  72. Kreisberg RA, Hershman JM, Spenney JG, Boshell BR, Pennington LF (1970) Biochemistry of extrapancreatic tumor hypoglycemia. Diabetes 19: 248–258PubMedGoogle Scholar
  73. Kumar D, Mehtalia SD, Miller LV (1974) Diagnostic use of glucagon-induced insulin response. Studies in patients with insulinoma or other hypoglycemic conditions. Ann Intern Med 80: 697–701Google Scholar
  74. Kushner RS, Lemli L, Smith DW (1963) Zinc glucagon in the management of idiopathic hypoglycemia. J Pediatr 63: 111 1–1115Google Scholar
  75. Landau BR, Levie HJ, Hertz R (1958) Prolonged glucagon administration in a case of hyperinsulinism due to disseminated isletcell carcinoma. N Engl J Med 259: 296–288Google Scholar
  76. Langs HM, Friedberg D (1965) Stimulation of insulin secretion by glucagon. Clin Res 13: 548Google Scholar
  77. Laqueur HP, LaBurt HA (1960) Experiences with low-zinc insulin, with semilente insulin, with glucagon and adrenalin-thiamin in insulin coma treatment. J Neuropsychiatry 2: 86–92Google Scholar
  78. Lefèbvre P, Luyckx A (1966) Glucagon-stimulated insulin release. Lancet 1: 1040Google Scholar
  79. Lefèbvre PJ, Luyckx AS, Lecomte M J (1976) Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon. In: Andreani D, Lefèbvre PJ, Marks V (eds) Hypoglycemia. Proceedings of the European Symposium. Thieme, Stuttgart, pp 91–98Google Scholar
  80. Lewis GM, Spencer-Peet J, Stewart KM (1963) Infantile hypoglycaemia due to inherited deficiency of glycogen synthetase in liver. Arch Dis Child 38: 40–48PubMedGoogle Scholar
  81. Limbeck GA, Kelley YC (1965) “Double-barrel” glucagon test: correlation with enzyme assays in limit dextrinosis. Am J Dis Child 109:162–164Google Scholar
  82. Lins PE, Efendic S (1979) Responses of patients with insulinomas to stimulators and inhibitors of insulin release that have been linked with cyclic adenosine monophosphate. Diabetes 28: 190–195PubMedGoogle Scholar
  83. Ljungström B (1964) Glucagon treatment of spontaneous hyperglycemia (in Norwegian). Nord Med 71: 177–179Google Scholar
  84. Lowe CU, Mosovich LL (1965) The paradoxical effect of alcohol on carbohydrate metabolism in four patients with liver glycogen disease. Pediatrics 35: 1005–1008PubMedGoogle Scholar
  85. Lowe CU, Sokal JE, Mosovich LL, Sarcione EJ, Dobray BH (1962) Studies in liver glycogen disease. Effects of glucagon and other agents on metabolic pattern and clinical status. Am J Med 33: 4–19PubMedGoogle Scholar
  86. MacCuish AC, Munro JF, Duncan LJP (1970) Treatment of hypoglycaemic coma with glucagon, intravenous dextrose, and mannitol infusion in a hundred diabetics. Lancet 2: 946–949PubMedGoogle Scholar
  87. MacLaren NK, Cowles C, Ozand PT, Shuttee R, Cornblath M (1975) Glycerol intolerance in a child with intermittent hypoglycemia. J Pediatr 86: 43–49PubMedGoogle Scholar
  88. Madison LL (1968) Ethanol-induced hypoglycemia. Adv Metab Disord 3: 85–109PubMedGoogle Scholar
  89. Mahler RF (1976) Disorders of glycogen metabolism. Clin Endocrinol Metab 5: 579–598PubMedGoogle Scholar
  90. Mariani MM, Loubatières A (1972) Récentes expériences concernant l’antagonisme entre certains sulfamides hypoglycemiants et le diazoxide. In: Austoni M, Scandellari C, Trissotto A, Federspil G (eds) Hypoglycaemia and diazoxide. Cedam, Padova, pp 33–49Google Scholar
  91. Marks LJ, Steinke J, Podolsky S, Egdahl RH (1974) Hypoglycemia associated with neoplasia. Ann NY Acad Sci 230: 147–160PubMedGoogle Scholar
  92. Marks V (1960) Response to glucagon by subjects with hyperinsulinism from islet cell tumours. Br Med J 1: 1539–1540PubMedGoogle Scholar
  93. Marks V (1962) The investigation of hypoglycaemia. In: Pyke DA (ed) Disorders of carbohydrate metabolism. Pitman, London, pp 229–239Google Scholar
  94. Marks V (1971) The biological significance of the insulinotropic effect of glucagon in man. In: Austoni M, Scandellari C, Federspil G, Trissotto A (eds) Current topics on glucagon. Cedam, Padova, pp 63–71Google Scholar
  95. Marks V (1976) Hypoglycaemia. 2. Other causes. Clin Endocrinol Metab 5: 769–782PubMedGoogle Scholar
  96. Marks V, Alberti KGMM (1976) Selected tests of carbohydrate metabolism. Clin Endocrinol Metab 5: 805–820PubMedGoogle Scholar
  97. Marks Y, Rose FC (1981) Hypoglycaemia, 2nd edn. Blackwell, Oxford Marks V, Samols E (1966) Hypoglycaemia of non-endocrine origin (non-islet cell tumours). Proc R Soc Med 59:338–340Google Scholar
  98. Marks V, Samols E (1968 a) Glucagon test for insulinoma: a chemical study in 25 cases. J Clin Pathol 21: 346–352PubMedGoogle Scholar
  99. Marks V, Samols E ( 1968 b) Glucagon mediated insulin release in man. In: Levine R, Pfeiffer EF (eds) Mechanism and regulation of insulin secretion. Il Ponte, Milan, pp 285–308Google Scholar
  100. Marks V, Samols E (1969) Diagnostic tests for evaluating hypoglycaemia. Excerpta Medica Int Congr Ser 172: 864–872Google Scholar
  101. Marrack D, Rose FC, Marks Y (1961) Glucagon and tolbutamide tests in the recognition of insulinomas. Proc R Soc Med 54: 749–751PubMedGoogle Scholar
  102. Marri G, Tyler J, Marks V, Samols E (1966) Stimolazione della secrezione insulinica nell’umo mediante glucagone. Minerva Med 57: 2733–2737PubMedGoogle Scholar
  103. Marri G, Cozzolino G, Palumbo R (1968) Glucagon in sulphonylurea hypoglycaemia. Lancet 1: 303PubMedGoogle Scholar
  104. McFadzean AJS, Young RTT (1969) Further observations on hypoglycaemia in hepatocellular carcinoma. Am J Med 47: 220–235PubMedGoogle Scholar
  105. McKiddie MT, Buchanan KD, Abernethy RJ (1969) Plasma insulin studies in the diagnosis of insulinoma. Scott Med J 14: 200–208PubMedGoogle Scholar
  106. McQuarrie I (1954) Idiopathic spontaneously occurring hypoglycemia in infants. Clinical significance of problems and treatment. Am J Dis Child 87: 399–428Google Scholar
  107. McQuarrie I, Bell ET, Zimmerman B, Wright WS (1950) Deficiency of alpha cells of pancreas as possible etiological factor in familial hypoglycemosis. Fed Proc 9: 337Google Scholar
  108. Mortensen O, Sondergaard G (1954) Galactosemia (galactose disease). Acta Paediatr Scand 43: 467–477Google Scholar
  109. Muhe E, Schricker KT, Raithel D (1969) Die Behandlung spontaner Hypoglycämien bei einem inoperablen Leberzellkarzinom durch Glucagon. Dtsch Med Wochenschr 94: 1781–1785PubMedGoogle Scholar
  110. Nabben FAE (1968) Transient hypoglycemia with leucine hypersensitivity not based on increased insulin production. Treatment with zinc glucagon (in Dutch). Maandschr Kindergeneeskd 36: 2–17PubMedGoogle Scholar
  111. Nitzan M, Kowadlo-Silbergeld A (1966) Responses to glucagon and epinephrine, and glycogen reserves in children with nondiabetic ketosis. Isr J Med Sci 2: 683–689PubMedGoogle Scholar
  112. Ohneda A, Maruhama Y, Itabashi H, Horigome K, Yanbe A, Ishii S, Chiba M, Kai Y, Abe R, Yamagata S (1975) Diagnostic value of intravenous glucagon test in insulinoma. Tohoku J exp Med 116: 205–211Google Scholar
  113. O’Keefe SJD, Marks V (1977) Lunchtime gin and tonic: a cause of reactive hypoglycaemia. Lancet 1: 1286–1288PubMedGoogle Scholar
  114. Paullada JJ, Lisci-Garmilla A, Gonzales-Angulo A, Jurado-Mendoza J, Quijano-Narezo M, Gomez-Peralta L, Doria-Medina M (1968) Hemangiopericytoma associated with hypoglycemia. Am J Med 44: 990–999PubMedGoogle Scholar
  115. Perheentupa J, Pitkanen E, Nikkila EA, Somersalo O, Hakosalo J (1962) Hereditary fructose intolerance: a clinical study of four cases. Ann Paediatr 8: 221–235Google Scholar
  116. Perkoff GT, Parker VJ, Hann RF (1962) The effects of glucagon in three forms of glycogen storage disease. J Clin Invest 41: 1099–1105PubMedGoogle Scholar
  117. Pfeifer MA, Wolter CF, Samols E (1978) Management of chlorpropamide-induced hypoglycemia with diazoxide. South Med J 71: 606–608PubMedGoogle Scholar
  118. Pfeiffer EM, Thum C, Raptis S, Beischer W, Ziegler R (1976) Hypoglycemia in diabetes. In: Andreani D, Lefebvre P, Marks Y (eds) Hypoglycemia. Procedings of the European Symposium. Thieme, Stuttgart, pp 112–126Google Scholar
  119. Pincus I J, Rutman JZ (1953) Glucagon, the hyperglycemic agent in pancreatic extracts. Arch Intern Med 92: 666–667Google Scholar
  120. Pi-Sunyer FX, van Itallie TB, Zintel HA (1969) Insulin stimulatory tests in a patient with islet cell adenoma. Am J Surg 118: 95–99PubMedGoogle Scholar
  121. Porte D, Graber AL, Kuzuya T, Williams RH (1966) The effect of epinephrine on immunoreactive insulin levels in man. J Clin Invest 45: 228–236PubMedGoogle Scholar
  122. Rizza RA, Gerich JE (1979) Persistent effect of sustained hyperglucagonaemia on glucose production in man. J Clin Endocrinol Metab 48: 352–355PubMedGoogle Scholar
  123. Rosenbloom AL (1972) Ketotic (idiopathic glucagon unresponsive) hypoglycaemia: diazoxide effects. Arch Dis Child 47: 544–549PubMedGoogle Scholar
  124. Rosenbloom AL, Smith DW, Cohan RC (1966) Zinc glucagon in idiopathic hypoglycemia of infancy. Am J Dis Child 112: 107–111PubMedGoogle Scholar
  125. Rossi E (1959) Glucagon. Triangle 4: 13Google Scholar
  126. Roth H, Thier S, Segal S (1966) Zinc-glucagon in the management of refractory hypoglycemia due to insulin-producing tumors. N Engl J Med 274: 493–497PubMedGoogle Scholar
  127. Samols E, Holdsworth D (1968) Disturbances of carbohydrate metabolism: liver disease. In: Dickens F, Rändle PJ, Whelan WJ (eds) Carbohydrate metabolism and its disorders. Academic, London, pp 289–336Google Scholar
  128. Samols E, Marks V (1963) Insulin assay in insulinomas. Br Med J 1: 507–510PubMedGoogle Scholar
  129. Samols E, Marks V (1966) Application of insulin radioimmunoassay in diagnosis and clinical investigation. In: Proceedings of the conference on problems connected with the preparation and use of labelled proteins in tracer studies, Euratom, Pisa, pp 285–300Google Scholar
  130. Samols E, Marri G, Marks V (1965) Promotion of insulin secretion by glucagon. Lancet 1: 415–516Google Scholar
  131. Samols E, Marri G, Marks Y (1966) Interrelationship of glucagon, insulin, and glucose. The insulinogenic effect of glucagon. Diabetes 15: 855–866Google Scholar
  132. Scarlett JA, Mako ME, Rubenstein AH, Blix PM, Goldman J, Horwitz DL, Tager H, Jaspan JB, Stjernholm MR, Olefsky JM (1977) Factitious hypoglycemia: diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies. N Engl J Med 297: 1029–1032PubMedGoogle Scholar
  133. Schulman JL, Greben SE (1957) The effect of glucagon on the blood glucose level and the clinical state in the presence of marked insulin hypoglycemia. J Clin Invest 36: 74–80PubMedGoogle Scholar
  134. Schulman JL, Saturen P (1954) Glycogen storage disease of the liver. I. Clinical studies during the early neonatal period. Pediatrics 14: 632–645Google Scholar
  135. Service FJ, Horwitz DL, Rubenstein AH, Kuzaya H, Mako ME, Reynolds C, Molnar GD (1977) C-peptide suppression test for insulinoma. J Lab Clin Med 90: 180–186PubMedGoogle Scholar
  136. Shipp JC, Delcher HK, Munroe JF (1964) Treatment of insulin hypoglycemia in a diabetic camp. A comparison of glucagon (1 and 2 mg) and glucose. Diabetes 13: 645–648PubMedGoogle Scholar
  137. Sizonenko PC, Paunier L, Vallotton MB, Terraz M, Scholer-Markovic D (1972) Childhood hypoglycaemia: plasma glucose and renin response to deoxyglucose for assessment of adrenal medulla responsiveness. Helv Paediatr Acta 27: 565–573PubMedGoogle Scholar
  138. Sokal JE, Lowe CU, Sarcione EJ, Mosovich LL, Doray BH (1961) Studies of glycogen metabolism in liver glycogen disease (von Gierke’s disease). Six cases with similar metabolic abnormalities and responses to glucagon. J Clin Invest 40: 364–374Google Scholar
  139. Sokal JE, Lowe CJ, Sarcione EJ (1962) Liver glycogen disease (von Gierke’s disease). Arch Intern Med 109: 612–624PubMedGoogle Scholar
  140. Spellberg MA (1969) Treatment of glycogen storage disease. Am J Gastroenterol 52: 45–47PubMedGoogle Scholar
  141. Steinitz K (1967) Laboratory diagnosis of glycogen disease. Adv Clin Chem 9: 227–354PubMedGoogle Scholar
  142. Stephenson JBP, Hainsworth IR (1966) Ketotic hypoglycaemia in childhood. Proc Assoc Clin Biochem 5: 80–81Google Scholar
  143. Taunton OD, Greene HL, Stifel FB, Hofeldt FD, Lufkin EG, Hagler L, Herman Y, Herman RH (1978) Fructose-1,6-diphosphatase deficiency, hypoglycemia and response to folate therapy in a mother and her daughter. Biochem Med 19: 260–276PubMedGoogle Scholar
  144. Taylor JR, Sherratt HSA, Davies DM (1978) Intramuscular or intravenous glucagon for sulphonylurea hypoglycaemia. Eur J Clin Pharmacol 14: 125–127PubMedGoogle Scholar
  145. Tietze HU, Zurbriigg RP, Zuppinger J A, Joss EE, Kaser H (1972) Occurrence of impaired Cortisol regulation in children with hypoglycemia associated with adrenal medullary hyporesponsiveness. J Clin Endocrinol Metab 34: 948–958PubMedGoogle Scholar
  146. Turner DS, Mclntyre N (1966) Stimulation by glucagon of insulin release from rabbit pancreas in vitro. Lancet 1: 351–352PubMedGoogle Scholar
  147. Turner RC (1976) The diagnosis of insulinomas and other causes of fasting hypoglycaemia. In: Andreani D, Lefebvre P, Marks V (eds) Hypoglycemia: proceedings of the european symposium. ( Hormone and Metabolic Research Supplement Series) Thieme, Stuttgart, pp 40–45Google Scholar
  148. Turner RC, Heding LG (1977) Plasma pro-insulin, C-peptide and insulin in diagnostic suppression tests for insulinomas. Diabetologia 13: 571–577PubMedGoogle Scholar
  149. van Itallie TB (1956) Glucagon: physiological and clinical considerations. N Engl J Med 254: 794–803Google Scholar
  150. van Itallie T, Bentley WBA (1955) Glucagon-induced hyperglycemia as an index of liver function. J Clin Invest 34: 1730–1737Google Scholar
  151. Vidnes J, Oyasaeter S (1977) Glucagon deficiency causing severe neonatal hypoglycemia in a patient with normal insulin secretion. Pediatr Res 11: 943–947PubMedGoogle Scholar
  152. Vidnes J, Sovik O (1976) Gluconeogenesis in infancy and childhood. III. Deficiency of the extramitochondrial form of hepatic phosphoenolpyruvate carboxykinase in a case of persistent neonatal hypoglycaemia. Acta Paediatr Scand 65: 307–312Google Scholar
  153. Wagner T, Spranger J, Brunck HJ (1969) Kongenitaler-a-Zellmangel als Ursache einer chronischen infantilen Hypoglykämie? Monatsschr Kinderheilkd 117: 236–238PubMedGoogle Scholar
  154. Waife SO (1960) An integrated view of glucagon. J Mich Med Soc 59: 1519–1523Google Scholar
  155. Weinges KF (1959) Der Einfluß eines protrahiert wirkenden Glucagons auf den Blutzucker, das anorganische Serumphosphat und die Gesamtaminosäuren im Serum. Naunyn Schmiedebergs Arch J Exp Pathol 237: 22–26Google Scholar
  156. Widström A, Cerasi E (1973) On the action of tolbutamide in normal man. III. Interaction of tolbutamide with glucagon, aminophylline and arginine in stimulating insulin response. Acta Endocrinol (Copenh) 72: 532–544Google Scholar
  157. Yakovac WC, Baker L, Hummeler K (1971) Beta cell nesidioblastosis in idiopathic hypoglycemia of infancy. Pediatrics 79: 225–231Google Scholar
  158. Zuppinger KA (1975) Hypoglycemia in childhood. Evaluation of diagnostic procedures. Karger, MunichGoogle Scholar
  159. Zuppinger KA, Rossi E (1969) Metabolic studies in liver glycogen disease with special reference to lactate metabolism. Helv Med Acta 35: 406–422Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • V. Marks

There are no affiliations available

Personalised recommendations